Loading...
•
Mar 31, 2022
IDEX Q1 2022 Earnings Report
IDEX achieved record results driven by robust demand and strong operating performance.
Key Takeaways
IDEX Corporation reported record first-quarter results, with record sales of $751 million, up 15% overall and 12% organically. The company also achieved record EPS of $1.83, up 24%, and record adjusted EPS of $1.96, up 21% compared to Q1 2021.
Record reported EPS of $1.83, up 24% and record adjusted EPS of $1.96, up 21% vs. Q1 2021
Record orders of $856 million, up 20% overall and 16% organically vs. Q1 2021
Record sales of $751 million, up 15% overall and 12% organically vs. Q1 2021
Record reported operating margin of 25.0%, up 110 basis points vs. Q1 2021
IDEX
IDEX
IDEX Revenue by Segment
Revenue by Segment
Health & Science Technologies Revenue
CapyFin.comFluid & Metering Technologies Revenue
CapyFin.comFire & Safety/Diversified Products Revenue
CapyFin.com Forward Guidance
Full year 2022 organic sales growth is projected to be 6 to 8 percent, with an 8 to 9 percent organic sales increase in the second quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00 (adjusted EPS attributable to IDEX of $7.50 to $7.63) and second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74 (adjusted EPS attributable to IDEX of $1.85 to $1.90).
Positive Outlook
- Full year 2022 organic sales growth is projected to be 6 to 8 percent
- 8 to 9 percent organic sales increase in the second quarter of 2022 versus the prior year period
- Full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00
- Full year 2022 adjusted EPS attributable to IDEX of $7.50 to $7.63
- Second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74
Revenue & Expenses
Visualization of income flow from segment revenue to net income